[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350370-105":59,"doc-detail-350370-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","multi-omics-and-single-cell-dissection-reveals-ext1-as-a-glycosylation-linked-therapeutic-target-in-cancer","Multi-Omics and Single-Cell Dissection Reveals EXT1 as a Glycosylation-Linked Therapeutic Target in Cancer","","Glycosylation and inflammation are examined as coordinated forces in tumor progression, while the glycosyltransferases connecting these processes remain insufficiently characterized. Using multi-omics analyses, EXT1, an enzyme central to heparan sulfate biosynthesis, is assessed across pan-cancer TCGA cohorts and validated in pancreatic and lung adenocarcinoma samples through transcriptomics, survival modeling, single-cell RNA sequencing, DNA methylation profiling, pathway enrichment, docking, and immunohistochemistry. EXT1 shows broad upregulation and links to poor survival, stromal localization, immune checkpoint co-expression, pro-tumor pathway activation, and stage-dependent overexpression, supporting its biomarker and therapeutic value.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-and-single-cell-dissection-reveals-ext1-as-a-glycosylation-linked-therapeutic-target-in-cancer/350370/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-and-single-cell-dissection-reveals-ext1-as-a-glycosylation-linked-therapeutic-target-in-cancer/350370.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the study investigate about EXT1 in cancer?","Question",{"text":113,"@type":114},"The study investigates EXT1 as a glycosylation-linked therapeutic target by assessing how it connects glycosylation and inflammation-related tumor progression.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which cancers and datasets were used for validation?",{"text":118,"@type":114},"Analyses used TCGA pan-cancer cohorts and validation in pancreatic adenocarcinoma (PAAD) and lung adenocarcinoma (LUAD) tissue microarrays.",{"name":120,"@type":111,"acceptedAnswer":121},"What evidence supports EXT1 as clinically relevant?",{"text":122,"@type":114},"EXT1 upregulation correlates with poor survival outcomes, shows stage-dependent overexpression by immunohistochemistry, localizes to stromal cells and co-expresses immune checkpoint markers, and relates to promoter hypomethylation and activation of pro-tumor pathways.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350370,1790633987,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":36,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[http://doi.org/10.32604/or.2026.070445](http://doi.org/10.32604/or.2026.070445)  \nARTICLE  \nMulti-Omics and Single-Cell Dissection Reveals EXT1 as a Glycosylation-Linked Therapeutic Target in Cancer  \nWen-Hsin Hsu 1,2,\\# , Kai-Fu Chang3,4,\\# , Chih-Hsuan Chang3,4 , Hui-Ru Lin5,6 , Chi-Jen Wu5,7 , Ching-Chung Ko8,9,10 , Cheng-Chun Wu 11 , Yu-Cheng Ho 11 , Chih-Chun Lin 12 ,  \nChien-Han Yuan3,5,13,14 , Sachin Kumar 15,16, Dahlak Daniel Solomon 15 , Fitria Sari Wulandari 15 , Juan Lorell Ngadio 17 , Do Thi Minh Xuan 18 , Chung-Bao Hsieh 19 , Chung-Chieh Chiao20 , Ngoc Uyen Nhi Nguyen21,22 , Chih-Yang Wang 15,20  \nand Yung-Kuo Lee3,4,5, *  \n1Department of Emergency Medicine, Kaohsiung Armed Forces General Hospital, National Defense Medical University, Kaohsiung, Taiwan  \n2Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan  \n3Medical Laboratory, Medical Education and Research Center, Kaohsiung Armed Forces General Hospital, National Defense Medical University, Kaohsiung, Taiwan  \n4Division of Experimental Surgery Center, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan  \n5Institute of Medical Science and Technology, National Sun Yat-Sen University, Kaohsiung, Taiwan  \n6Nursing Department, Kaohsiung Armed Forces General Hospital, National Defense Medical University, Kaohsiung, Taiwan  \n7 College of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan  \n8Department of Medical Imaging, Chi-Mei Medical Center, Tainan, Taiwan  \n9Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan  \n10School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan  \n11School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan  \n12Department of Physical Therapy, I-Shou University, Kaohsiung, Taiwan  \n13Department of Otolaryngology, Kaohsiung Armed Forces General Hospital, National Defense Medical University, Kaohsiung, Taiwan  \n14Department of Otolaryngology, National Defense Medical Center, Taipei, Taiwan  \n15 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan  \n16Faculty of Applied Sciences and Biotechnology, Shoolini University of Biotechnology and Management Sciences, Himachal Pradesh, India  \n17Department of Bioinformatics, School of Life Sciences, Indonesia International Institute for Life Sciences, Jl. Pulomas Barat Kav  \n88, Jakarta Timur, Indonesia  \n18Faculty of Pharmacy, Van Lang University, 69/68 Dang Thuy Tram Street, Binh Loi Trung Ward, Ho Chi Minh City, Vietnam  \n19Division of General Surgery, Department of Surgery, Tri-Service General Hospital, Taipei, Taiwan  \n20PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan  \n21 Center for Regenerative Medicine, University of South Florida Health Heart Institute, Tampa, FL, USA  \n22Division of Cardiology, Department of Internal Medicine, Morsani School of Medicine, University of South Florida, Tampa, FL, USA  \n*[Corresponding Author: Yung-Kuo Lee. Email: yungkuolee@gmail.com](Corresponding Author: Yung-Kuo Lee. Email: yungkuolee@gmail.com)  \n[\\#](# These authors contributed equally to this work)[ These authors contributed equally to this work](# These authors contributed equally to this work)  \nReceived: 16 July 2025; Accepted: 04 February 2026; Published: 21 May 2026  \nCopyright © 2026 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nABSTRACT: Background: Glycosylation and inflammation are pivotal in tumor progression, yet the specific glycosyltransferases bridging these processes remain poorly def","cbCaiv8tWnxj7Urt","https://ap.wps.com/l/cbCaiv8tWnxj7Urt","pdf",29408802,"English","# Abstract\n## Study objective\n## Methods\n## Key findings\n## Conclusions","[{\"question\":\"What does the study investigate about EXT1 in cancer?\",\"answer\":\"The study investigates EXT1 as a glycosylation-linked therapeutic target by assessing how it connects glycosylation and inflammation-related tumor progression.\"},{\"question\":\"Which cancers and datasets were used for validation?\",\"answer\":\"Analyses used TCGA pan-cancer cohorts and validation in pancreatic adenocarcinoma (PAAD) and lung adenocarcinoma (LUAD) tissue microarrays.\"},{\"question\":\"What evidence supports EXT1 as clinically relevant?\",\"answer\":\"EXT1 upregulation correlates with poor survival outcomes, shows stage-dependent overexpression by immunohistochemistry, localizes to stromal cells and co-expresses immune checkpoint markers, and relates to promoter hypomethylation and activation of pro-tumor pathways.\"}]","Multi-Omics and Single-Cell Dissection Reveals EXT1 as a Glycosylation-Linked Therapeutic Target in Cancer | PDF",1790088715,101,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a99c68316ffb35ab0dba7201610958bc.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e987c19e9cc2e2ad50299eeb474f54e3.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a32c5541f893ccb06c748b217006e7e.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/792a726f25aac84bc13d491f05355110.webp",980,1268]